Innoscripta (1INN) Q1 2026 TU earnings summary

Executive summary

• Achieved dynamic growth in Q1 2026, continuing momentum from 2025 with strong operational execution.

• Consolidated net income for Q1 2026 was €18.39 million, up from €10.93 million in Q1 2025, reflecting strong profitability growth.

• Revenues for the quarter reached €40.3m, a significant increase compared to €25.58 million in the prior year period.

• Focused on revolutionizing R&D process management through an integrated software platform.

• Cash flow from operating activities rose to €23.03 million, up from €14.21 million year-over-year.

Financial highlights

• Q1 2026 adjusted revenue reached €40.3m, up 57.0% year-over-year from Q1 2025.

• EBIT for Q1 2026 was €27.3m, a 64% increase from Q1 2025, with a margin of 67.7%.

• Consolidated net income grew by 68% to €18.39 million compared to Q1 2025.

• Cash and cash equivalents at period end were €68.60 million, up from €37.47 million a year earlier.

• Total assets rose to €124.77 million from €74.83 million at March 2025.

Outlook and guidance

• Management expects continued growth, leveraging operational efficiencies and scalable business model.

• The review report did not identify any issues that would affect the true and fair view of the group’s financial position, supporting a positive outlook.